Pari Homepage

Results will be updated as you type

News, Publications & Insights

Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.

Digital illustration of lungs with connected data structures and technical graphics, featuring the eFlow® Technology logo.

Categories

  • PARI News
  • Partner News
  • PARI Publications
  • Publications
  • eFlow Integrated

Posts of category: Partner News

Recent announcements, achievements, and development milestones from PARI's pharmaceutical partners utilizing eFlow® Technology.

Published
March 30, 2023
Category
  • Partner News

Avalyn Pharma Reports Results of Phase 1 Study of AP02 in Healthy Volunteers and Participants with Idiopathic Pulmonary Fibrosis

Published
March 23, 2023
Category
  • Partner News

Avalyn Pharma Publishes Phase 1b ATLAS Results Demonstrating Stabilization of Lung Function at 24 and 48 Weeks with AP01 and Favorable Safety Profile

Published
March 15, 2023
Category
  • Partner News

ReCode Therapeutics Announces First Participants Dosed in a Phase 1 Healthy Volunteer Clinical Trial of Novel Disease-Modifying Genetic Medicine, RCT1100 for the Treatment of Primary Ciliary Dyskinesia

Published
January 9, 2023
Category
  • Partner News

Spexis reports solid safety and pharmacokinetics results from first-in-human study with inhaled murepavadin, a novel macrocycle compound

Published
November 2, 2022
Category
  • Partner News

First Patient Enrolled in Phase 2 Clinical Study Evaluating ARINA-1 for the Treatment of NCFBE

Previous page
of 11
Next page

Back to overview

  1. eFlow Partnering
  2. News & Publications
  3. Categories
Link to PARI at LinkedIn

+49 (0) 8151 279 279
 

Contact

  • Career
  • Press portal
  • Partner with us
  • PARI INT
  • Imprint
  • Data Protection
  • Cookie Consent
  • Accessibility Statement
  • General Terms and conditions

© 2026 PARI GmbH Spezialisten für effektive Inhalation